HPV screening is expanding, follow‑up is the weak link

Human papillomavirus screening is getting easier to start and harder to finish. That is the shape of the latest cervical-cancer prevention push: more women are being reached through lower-friction screening, including self-collected tests and large public screening drives, but every extra positive result creates a second problem that health systems have to solve quickly and clearly. (edexlive.com) Human papillomavirus, or HPV, is a very common virus, and most infections clear on their own. Cervical cancer usually develops when a high-risk HPV infection does not go away and instead lingers for years, causing abnormal cell changes that can turn into precancer and then cancer if they are not found and treated. (who.int) That long timeline is why screening matters. A screening test is not looking for cancer after symptoms appear; it is trying to catch the warning signal early enough that treatment can interrupt the process before invasive cancer develops. (who.int) The World Health Organization has turned that logic into a global target. Its cervical-cancer elimination strategy calls for 90% of girls to be fully vaccinated against HPV by age 15, 70% of women to be screened with a high-performance test by ages 35 and 45, and 90% of women identified with cervical disease to receive treatment. (who.int) That last number often gets less attention than the first two. Screening only changes outcomes if a woman with a positive result can move into triage, diagnostic follow-up, and treatment without getting lost between the lab result and the clinic door. (cervicalcanceraction.org) Recent reporting shows the front end of that system expanding. In New Delhi, the Delhi State Cancer Institute’s fifth Cancer Awareness, Prevention and Screening camp at Delhi Police Headquarters on April 7 offered free cancer services that included human papillomavirus DNA self-testing kits, cervical-cancer screening, consultations, and education. Coverage of the event said 18 HPV tests were performed, alongside 9 mammographies, 42 prostate-specific antigen tests, and 55 oral-cancer screenings. (edexlive.com) That Delhi camp did not appear out of nowhere. Earlier this year, Delhi’s Cancer Awareness, Prevention and Screening program was launched with mobile screening vans and self-test kits intended to bring mammography and HPV DNA testing closer to residents instead of waiting for patients to reach tertiary hospitals on their own. (thedailyjagran.com) Mongolia is now scaling the same idea at national level. On April 8, Xinhua reported that at least 20,000 women in their 30s and 40s will undergo HPV screening in Mongolia this year under a health-ministry-backed effort tied to the country’s cervical-cancer control program. (english.news.cn) Mongolia’s push fits a broader national strategy. The World Health Organization said in April 2025 that Mongolia had launched a Cervical Cancer Elimination Programme to expand prevention, early detection, and management, and described cervical cancer as the country’s second most common cancer among women and the leading cause of cancer-related deaths in women there. (who.int) The attraction of self-collection is simple: it removes friction. Instead of requiring every woman to begin with a pelvic exam and a clinician-collected sample, self-collection can let screening start in a more private, more acceptable, and sometimes more reachable way, especially for people who have never been screened or are overdue. (dceg.cancer.gov) In the United States, that shift has already begun to reshape guidance. The National Cancer Institute said in 2025 that new clinical guidelines support self-collected vaginal samples for primary HPV screening in health-care settings, and the Health Resources and Services Administration’s updated women’s preventive-services guidance now includes self-collected high-risk HPV testing in screening policy. (dceg.cancer.gov) But easier screening does not eliminate the need for follow-up; in some ways it makes follow-up more central. The American Cancer Society notes that self-collection can widen access, while expert guidance also emphasizes that many patients who test positive will need additional in-person steps, and one clinician communication guide says a positive self-collected result will require a follow-up visit with a speculum exam. (cancer.org) That is the weak link highlighted in recent commentary. A report published April 4 in The Vindicator warned readers not to ignore a positive high-risk HPV result, stressing that the result does not mean cancer is already present but does mean follow-up matters because persistent infection is what raises cancer risk over time. (vindy.com) The prevention side has its own bottleneck: vaccine confidence. In India, The Week reported on April 7 that urban vaccine hesitancy around HPV remains stubborn despite higher levels of access and information. The article described a mix of misinformation, discomfort around discussing sexual health, and parental fears about safety, fertility, and side effects as reasons uptake remains weaker than public-health officials want. (theweek.in) That hesitation comes at an awkward moment. India has also begun a major national vaccination drive: The Lancet reported that Prime Minister Narendra Modi unveiled a campaign on February 28, 2026, aiming to provide free HPV vaccination to 11.5 million girls aged 14 years during a 90-day push. (thelancet.com) Put together, the picture is not one of failure. It is one of a system moving from a screening-access problem to a continuity-of-care problem. When a city distributes self-test kits, or a country announces 20,000 screenings, the visible part is the sample collection. The less visible part is the chain that has to come next: lab capacity, result reporting, patient counseling, repeat visits, referral pathways, treatment slots, and reminders strong enough to bring a worried or confused patient back into care. That inference follows directly from the structure of HPV screening programs and from the follow-up requirements attached to positive self-collected tests. (apps.who.int) Public-health campaigns often celebrate the first contact because it is easy to count kits handed out and women screened. Cervical-cancer prevention is won later, when a positive result is explained in plain language, the next appointment is made quickly, and the patient actually receives the care that turns a warning sign into a prevented cancer. (cervicalcanceraction.org)